PDX
PAXS
PDI

IVASCYN DANIEL J

CIK: 0001201895

IVASCYN DANIEL J's purchase track record

IVASCYN DANIEL J has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
4/27/2026PDX$592K+5.1%pending
1/31/2022PAXS$5.00M-11.8%-12.5%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 26, 2026

PDX Featured in SeekingAlpha's 10 Best CEFs List for September 2026. PDX was named one of SeekingAlpha's 10 best closed‑end funds for September 2026, with an average yield of about 10%. The fund sits near the lower end of its 52‑week range, and its RSI of 39.8 suggests it is not yet overbought. A recent volume spike and a support rejection at $20.63 may signal a short‑term test of that level.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 10, 2026

PDI Gains Attention with 18.7% Yield and Rating Upgrade. PDI, a closed‑end bond fund, recently received a rating upgrade and is offering an 18.7% yield. The fund’s 52‑week range is $13.73 to $19.96, and its trailing P/E is 11.4, indicating a relatively low valuation. These developments have drawn attention from income‑focused investors.

this person other insiders at PDI

Transaction History

PDX▲ Buy$592K
PAXS▲ Buy$5.0M
PDI▲ Buy—
PDI▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.